Roche | Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020
About this event
Access the replay of Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020. Roche | Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020 is an official webinar listing associated with Roche.
Visit the company-owned event page for the organizer's latest agenda, access details, availability, and registration or viewing instructions. UPCOMING provides this independent listing to help professionals discover the session.
Topics covered
Frequently asked questions
Who is hosting Roche | Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020?
Roche | Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020 is hosted by Roche.
When is Roche | Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020?
This session is available on demand.
Where does registration take place?
Registration or viewing is completed on Roche's website.
What format is this event?
This is an on-demand session that can be watched online.
Which topics does this event cover?
The event covers SaaS.
More from Roche
View all →See source for availability
Roche | Roche's Half-Year Results 2025 Media Conference
Roche
Available on demand
Roche | Roche’s virtual event on key neuromuscular data presented at the Muscular Dystrophy Association (MDA) scientific and clinical conference 2022
Roche
See source for availability
Roche | Roche's Half-Year Results 2024 Media Conference
Roche